T Shiga

Summary

Affiliation: Tokyo Women's Medical University
Country: Japan

Publications

  1. doi request reprint Contributing factors to the apparent clearance of bepridil in patients with paroxysmal or persistent atrial fibrillation: analysis using population pharmacokinetics
    Tsuyoshi Shiga
    Department of Cardiology, Tokyo Women s Medical University, Tokyo, Japan
    Ther Drug Monit 35:367-73. 2013
  2. pmc Long-term prognosis of diabetic patients with acute myocardial infarction in the era of acute revascularization
    Ayako Takara
    Division of Cardiology, Saiseikai Kurihashi Hospital, Saitama, Japan
    Cardiovasc Diabetol 9:1. 2010
  3. ncbi request reprint Drug therapy for ventricular tachyarrhythmia in heart failure
    Tsuyoshi Shiga
    Department of Cardiology, Tokyo Women s Medical University, Shinjuku ku, Tokyo 162 8666, Japan
    Circ J 71:A90-6. 2007
  4. ncbi request reprint Influence of cilnidipine or nisoldipine on sympathetic activity in healthy male subjects
    Tsuyoshi Shiga
    Department of Cardiology, Tokyo Women s Medical University, Tokyo, Japan
    Heart Vessels 22:404-9. 2007
  5. doi request reprint Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry
    T Shiga
    Department of Cardiology, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo 162 8666, Japan
    Heart 95:216-20. 2009
  6. doi request reprint Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia
    Tsuyoshi Shiga
    Department of Cardiology, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo 162 8666, Japan
    Resuscitation 81:47-52. 2010
  7. ncbi request reprint Amiodarone decreases plasma brain natriuretic peptide level in patients with heart failure and ventricular tachyarrhythmia
    Tsuyoshi Shiga
    Department of Cardiology, The Heart Institute of Japan, Tokyo Women s Medical University, Tokyo, Japan
    Cardiovasc Drugs Ther 17:325-33. 2003
  8. doi request reprint Angiotensin receptor blocker-based therapy and cardiovascular events in hypertensive patients with coronary artery disease and impaired renal function
    Tsuyoshi Shiga
    Department of Cardiology, Tokyo Women s Medical University, Tokyo, Japan
    Blood Press 19:359-65. 2010
  9. ncbi request reprint Beta-blocker therapy combined with low-dose pimobendan in patients with idiopathic dilated cardiomyopathy and chronic obstructive pulmonary disease: report on two cases
    Tsuyoshi Shiga
    Department of Cardiology, The Heart Institute of Japan, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku, Tokyo 162 8666, Japan
    Cardiovasc Drugs Ther 16:259-63. 2002
  10. doi request reprint Pharmacokinetics of intravenous amiodarone and its electrocardiographic effects on healthy Japanese subjects
    Tsuyoshi Shiga
    Department of Cardiology, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo, 162 8666, Japan
    Heart Vessels 26:274-81. 2011

Collaborators

Detail Information

Publications35

  1. doi request reprint Contributing factors to the apparent clearance of bepridil in patients with paroxysmal or persistent atrial fibrillation: analysis using population pharmacokinetics
    Tsuyoshi Shiga
    Department of Cardiology, Tokyo Women s Medical University, Tokyo, Japan
    Ther Drug Monit 35:367-73. 2013
    ....
  2. pmc Long-term prognosis of diabetic patients with acute myocardial infarction in the era of acute revascularization
    Ayako Takara
    Division of Cardiology, Saiseikai Kurihashi Hospital, Saitama, Japan
    Cardiovasc Diabetol 9:1. 2010
    ..The long-term prognosis of diabetic patients with acute myocardial infarction (AMI) treated by acute revascularization is uncertain, and the optimal pharmacotherapy for such cases has not been fully evaluated...
  3. ncbi request reprint Drug therapy for ventricular tachyarrhythmia in heart failure
    Tsuyoshi Shiga
    Department of Cardiology, Tokyo Women s Medical University, Shinjuku ku, Tokyo 162 8666, Japan
    Circ J 71:A90-6. 2007
    ..The pure class III antiarrhythmic drug, nifekalant, is useful in the emergency treatment of VT/VF...
  4. ncbi request reprint Influence of cilnidipine or nisoldipine on sympathetic activity in healthy male subjects
    Tsuyoshi Shiga
    Department of Cardiology, Tokyo Women s Medical University, Tokyo, Japan
    Heart Vessels 22:404-9. 2007
    ..017). Postural hypotension was not observed. There was no difference in mental arithmetic-induced sweating between the two drugs. Cilnidipine, but not nisoldipine, might have a weak inhibitory effect on reflex sympathetic activity...
  5. doi request reprint Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry
    T Shiga
    Department of Cardiology, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo 162 8666, Japan
    Heart 95:216-20. 2009
    ..To determine the incidence of sudden cardiac death (SCD) according to left ventricular ejection fraction (LVEF) in survivors of myocardial infarction (MI) in the primary percutaneous coronary intervention (PCI) era...
  6. doi request reprint Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia
    Tsuyoshi Shiga
    Department of Cardiology, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo 162 8666, Japan
    Resuscitation 81:47-52. 2010
    ..To compare the efficacy and safety of nifekalant, a pure class III anti-arrhythmic drug, and lidocaine in patients with shock-resistant in-hospital ventricular fibrillation (VF) or ventricular tachycardia (VT)...
  7. ncbi request reprint Amiodarone decreases plasma brain natriuretic peptide level in patients with heart failure and ventricular tachyarrhythmia
    Tsuyoshi Shiga
    Department of Cardiology, The Heart Institute of Japan, Tokyo Women s Medical University, Tokyo, Japan
    Cardiovasc Drugs Ther 17:325-33. 2003
    ..Amiodarone appears to have a decreasing effect on plasma BNP level, as well as an antiarrhythmic effect, in patients with heart failure and ventricular tachyarrhythmia...
  8. doi request reprint Angiotensin receptor blocker-based therapy and cardiovascular events in hypertensive patients with coronary artery disease and impaired renal function
    Tsuyoshi Shiga
    Department of Cardiology, Tokyo Women s Medical University, Tokyo, Japan
    Blood Press 19:359-65. 2010
    ....
  9. ncbi request reprint Beta-blocker therapy combined with low-dose pimobendan in patients with idiopathic dilated cardiomyopathy and chronic obstructive pulmonary disease: report on two cases
    Tsuyoshi Shiga
    Department of Cardiology, The Heart Institute of Japan, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku, Tokyo 162 8666, Japan
    Cardiovasc Drugs Ther 16:259-63. 2002
    ..The combination of beta-blocker with low-dose pimobendan may be helpful for patients with DCM and COPD, but further clinical investigation is required...
  10. doi request reprint Pharmacokinetics of intravenous amiodarone and its electrocardiographic effects on healthy Japanese subjects
    Tsuyoshi Shiga
    Department of Cardiology, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo, 162 8666, Japan
    Heart Vessels 26:274-81. 2011
    ..After a single infusion of amiodarone at doses of 1.25-5.0 mg/kg, serum concentrations increased in a dose-dependent manner. A single intravenous amiodarone dose barely affected the electrocardiographic parameters and was well tolerated...
  11. ncbi request reprint Effect of low-dose amiodarone on atrial fibrillation or flutter in Japanese patients with heart failure
    Tsuyoshi Shiga
    Department of Cardiology, The Heart Institute of Japan, Tokyo Women s Medical University
    Circ J 66:600-4. 2002
    ..Adverse effects requiring the discontinuation of amiodarone therapy occurred in 16% of patients. Low-dose amiodarone therapy may prevent AF or flutter in Japanese patients with heart failure...
  12. ncbi request reprint Clinical outcome in patients with paroxysmal or persistent atrial fibrillation receiving bepridil
    Tsuyoshi Shiga
    Department of Cardiology, Tokyo Women s Medical University, Tokyo, Japan
    Circ J 75:1334-42. 2011
    ..It is unknown whether bepridil improves cardiovascular events in atrial fibrillation (AF) patients, so this study evaluated the clinical outcome in paroxysmal or persistent AF patients receiving bepridil...
  13. ncbi request reprint Electrophysiological characteristic of a patient exhibiting the short-coupled variant of torsade de pointes
    T Shiga
    Department of Cardiology, The Heart Institute of Japan, Tokyo Women s Medical University, Tokyo, Japan
    J Electrocardiol 34:271-5. 2001
    ....
  14. ncbi request reprint Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan
    T Shiga
    Department of Cardiology, The Heart Institute of Japan, Tokyo Women s Medical University
    Jpn Circ J 65:958-60. 2001
    ..It is important to monitor for arrhythmia when hyperthyroidism develops during amiodarone therapy...
  15. ncbi request reprint Reverse use-dependent QT prolongation during infusion of nifekalant in a case of recurrent ventricular tachycardia with old myocardial infarction
    T Shiga
    Department of Cardiology, The Heart Institute of Japan, Tokyo Women's Medical University, Tokyo, Japan
    J Electrocardiol 34:77-80. 2001
    ..It is therefore considered advisable to monitor the heart rate and QTc interval during administration of nifekalant by continuous intravenous infusion...
  16. doi request reprint Gender difference in arrhythmic occurrences in patients with nonischemic dilated cardiomyopathy and implantable cardioverter-defibrillator
    Atsushi Takahashi
    Department of Cardiology, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo, 162 8666, Japan
    Heart Vessels 25:150-4. 2010
    ..17). In high-risk patients with nonischemic dilated cardiomyopathy who received ICD, there was no gender difference in the incidence of appropriate ICD therapy or electrical storm...
  17. ncbi request reprint Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy
    M Naganuma
    Department of Pharmacy, The Heart Institute of Japan, Tokyo Women's Medical University, Tokyo, Japan
    J Cardiovasc Pharmacol Ther 6:363-7. 2001
    ..CONCLUSIONS: It was suggested that inhibition of CYP2C9 by desethylamiodarone, the active metabolite of amiodarone, plays an important role in the interaction of warfarin and amiodarone...
  18. doi request reprint Impact of renal dysfunction on appropriate therapy in implantable cardioverter defibrillator patients with non-ischaemic dilated cardiomyopathy
    Atsushi Takahashi
    Department of Cardiology, Tokyo Women s Medical University, Tokyo, Japan
    Europace 11:1476-82. 2009
    ..To examine the effect of renal dysfunction on the occurrence of life-threatening ventricular arrhythmia in patients with non-ischaemic dilated cardiomyopathy and implantable cardioverter defibrillator (ICD)...
  19. ncbi request reprint Low-dose systemic phosphodiesterase III inhibitor pimobendan combined with prostacyclin therapy in a patient with severe primary pulmonary hypertension
    Eri Watanabe
    Department of Cardiology, The Heart Institute of Japan, Tokyo Women s Medical University, Tokyo, Japan
    Cardiovasc Drugs Ther 17:375-9. 2003
    ..We suggest that low-dose pimobendan may enhance the hemodynamic effect of prostacyclin in severe PPH...
  20. ncbi request reprint Significance of 8-hydroxy-2'-deoxyguanosine levels in patients with idiopathic dilated cardiomyopathy
    Eri Watanabe
    Department of Cardiology, Aoyama Hospital, Tokyo Women s Medical University, Tokyo, Japan
    J Card Fail 12:527-32. 2006
    ..The aim of this study is to evaluate the clinical significance of the serum 8-OHdG and TRX of patients with chronic HF with idiopathic dilated cardiomyopathy (DCM)...
  21. ncbi request reprint Amiodarone distribution in human tissues after long-term therapy: a case of arrhythmogenic right ventricular cardiomyopathy
    Fumitaka Hosaka
    Department of Cardiology, The Heart Institute of Japan, Tokyo Women s Medical University, Japan
    Heart Vessels 16:154-6. 2002
    ..We anticipate that a low dose of amiodarone would be effective in preventing arrhythmia in some patients with ARVC...
  22. doi request reprint Improved survival in patients with continuous-flow ventricular assist device for bridge to heart transplantation
    M Ono
    Department of Cardiac Surgery, University of Tokyo, Tokyo, Japan
    Transplant Proc 45:2017-8. 2013
    ..In Japan, CFVAD is limited for BTT use. The waiting period for heart transplantation (HT) is long owing to donor shortage. We examined the results of CFVAD for BTT indication...
  23. ncbi request reprint Mild and short recurrence of type II amiodarone-induced thyrotoxicosis in three patients receiving amiodarone continuously for more than 10 years
    Kanji Sato
    Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women s Medical University, Tokyo, Japan
    Endocr J 53:531-8. 2006
    ..Furthermore, at least in Japan, it may be possible for patients with recurrent type II AIT to continue taking amiodarone...
  24. ncbi request reprint Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone
    Yuichiro Yamada
    Department of Cardiology, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo 162 8666, Japan
    Circ J 71:1610-6. 2007
    ..This study was designed to evaluate the incidence and clinical risk factors of APT, and the utility of a pulmonary function test or serum KL-6 assay to predict pulmonary toxicity in Japanese patients receiving low-dose amiodarone...
  25. ncbi request reprint Differential diagnosis and appropriate treatment of four thyrotoxic patients with Graves' disease required to take amiodarone due to life-threatening arrhythmia
    Kanji Sato
    Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women s Medical University, Tokyo
    Intern Med 47:757-62. 2008
    ..Surgical treatment of Graves' disease patients is recommended when immediate control of hyperthyroidism and heart failure is required...
  26. ncbi request reprint Syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by amiodarone: a report on two cases
    Haruhiko Ikegami
    Department of Cardiology, The Heart Institute of Japan, Tokyo Women s Medical University, Shinjuku, Tokyo, Japan
    J Cardiovasc Pharmacol Ther 7:25-8. 2002
    ..The syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by amiodarone during long-term therapy seems to be rare among adverse effects...
  27. ncbi request reprint [Cervical aortic arch complicated with thoracic aortic aneurysms that occurred two times]
    Yuichiro Minami
    Department of Cardiology, Heart Institute of Japan, Tokyo Women s Medical University, Tokyo
    Nihon Naika Gakkai Zasshi 91:2186-8. 2002
  28. ncbi request reprint Apical hypertrophic cardiomyopathy with aneurysmal degeneration of the apex
    Akira Sato
    Department of Cardiology, The Heart Institute of Japan, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo 162 8666, Japan
    Heart Vessels 18:53-4. 2003
  29. ncbi request reprint Antiarrhythmic effect of nifekalant on atrial tachyarrhythmia in four patients with severe heart failure
    Tsuyoshi Shiga
    Department of Cardiology, Heart Institute of Japan, Tokyo Women s Medical University, Kawada cho 8 1, Shinjuku ku, Tokyo 162 8666
    J Cardiol 39:159-64. 2002
    ..Intravenous nifekalant was administered in four patients with atrial tachyarrhythmia and severe heart failure to terminate or prevent atrial tachyarrhythmia...
  30. ncbi request reprint Hemodynamics during chronic amiodarone administration in Japanese patients with idiopathic dilated cardiomyopathy and ventricular arrhythmia: a retrospective study
    Tsuyoshi Suzuki
    Department of Cardiology, Heart Institute of Japan, Tokyo Women s Medical University, Kawada cho 8 1, Shinjuku ku, Tokyo 162 8666
    J Cardiol 41:169-73. 2003
    ..The hemodynamic changes during chronic amiodarone administration were retrospectively studied in patients with idiopathic dilated cardiomyopathy and ventricular arrhythmia...
  31. ncbi request reprint Plasma concentration profile of orally administered pimobendan and plasma brain natriuretic peptide level in patients with severe heart failure
    Michi Wakaumi
    Cardiovasc Drugs Ther 17:291-3. 2003
  32. ncbi request reprint Atrial fibrillation and rheumatic valvular heart disease: usefulness of very-low-dose amiodarone
    Tsuyoshi Shiga
    Chin Med J (Engl) 119:2027-9. 2006
  33. ncbi request reprint Comparison of cilostazol and ticlopidine for one-month effectiveness and safety after elective coronary stenting
    Masayuki Hashiguchi
    Department of Medication Use Analysis and Clinical Research, Meiji Pharmaceutical University, 2 522 1 Noshio, Kiyose, Tokyo 204 8588, Japan
    Cardiovasc Drugs Ther 18:211-7. 2004
    ..To compare the oral antiplatelets, phosphodiesterase III inhibitor cilostazol and the thienopyridine ticlopidine, for one-month effectiveness and safety as an adjunctive therapy after coronary stenting...
  34. pmc Pilsicainide in breast milk from a mother: comparison with disopyramide and propafenone
    Michi Wakaumi
    Br J Clin Pharmacol 59:120-2. 2005
  35. ncbi request reprint [Lethal arrhythmia associated with heart failure]
    Tsuyoshi Shiga
    Department of Cardiology, Tokyo Women s Medical University
    Nihon Rinsho 65:364-8. 2007